ARCHIVES

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

This article is from The Cancer Letter archive.

Vol. 24 No. 35 | September 18, 1998

Download PDF Visit The Full Archive

Related Articles

Subgroup Agrees Five Compounds Are Carcinogens

January 20, 1978

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011

Funding opportunities listed.

April 23, 2004

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995